טוען...
TNF Polymorphism Affects Transplant Outcome in Patients with MDS but not with CML, Independent of the Presence of HLA-DR15
Both presence of HLA-DR15 and tumor necrosis factor-α (TNF) levels have been reported to affect outcome after hematopoietic cell transplantation (HCT). Patients with myelodysplastic syndromes (MDS) show a high prevalence of HLA-DR15 and express high levels of TNF in the bone marrow. The present anal...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2975858/ https://ncbi.nlm.nih.gov/pubmed/20541027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.06.003 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|